JPRN-UMIN000006710
Completed
未知
Assessment on safety of intravenously administered trastuzumab with 100 ml saline solution in HER2 positive breast cancer - Assessment on safety of intravenously administered trastuzumab with 100 ml saline solution in HER2 positive breast cancer
ConditionsBreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Shiga University of Medical Science
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Inflammatory breast cancer (2\)Serious underlying disease (3\)Pregnant or lactating patients (4\)Cumulative administration of previous treatment is \> 360 mg/m2 of doxorubicin or \> 720 mg/m2 of epirubicin (5\)Ineligible based on physicians' decision
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled studyModerate-to-severe COVID-19 pneumoniaMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-003614-13-ITImmuneMed Inc.105
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency AnemiaEUCTR2019-003821-70-PLAmerican Regent, Inc.10
Recruiting
Phase 2
Investigating the effect of the bone marrow-drived mesenchymal stem cells in MS patients under fingolimod therapy.IRCT20191004044975N1Vice-presidency for science and technology120
Active, not recruiting
Not Applicable
intravenous immunoglobulin for the treatment of infections in patients with post solid organ transplantation hypogammaglobulinemiainfections in patients with post solid organ transplantation IgG hypogammaglobulinemiaMedDRA version: 15.0Level: LLTClassification code 10054427Term: HypogammaglobulinemiaSystem Organ Class: 10021428 - Immune system disordersTherapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2012-001327-12-ESFundacion para la Investigación Biomédica del Hospital Gregorio Marañón